Early detection of transformation to BPDCN in a patient with MDS

BACKGROUND: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy characterized by neoplastic cells that are positive for CD123, CD4, BDCA2, and TCL1 and aberrant expression of CD56. Historically, patients with BPDCN have an unfavorable prognosis and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamoun, Kamal, Loghavi, Sanam, Pemmaraju, Naveen, Konopleva, Marina, Kroll, Michael, Nguyen-Cao, Madeleine, Hornbaker, Marisa, DiNardo, Courtney D., Kadia, Tapan, Jorgensen, Jeffrey, Andreeff, Michael, Hu, Shimin, Benton, Christopher B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174068/
https://www.ncbi.nlm.nih.gov/pubmed/30323983
http://dx.doi.org/10.1186/s40164-018-0117-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174068/
https://www.ncbi.nlm.nih.gov/pubmed/30323983
http://dx.doi.org/10.1186/s40164-018-0117-6

Ejemplares similares